2021
Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection
McPadden J, Warner F, Young HP, Hurley NC, Pulk RA, Singh A, Durant TJS, Gong G, Desai N, Haimovich A, Taylor RA, Gunel M, Dela Cruz CS, Farhadian SF, Siner J, Villanueva M, Churchwell K, Hsiao A, Torre CJ, Velazquez EJ, Herbst RS, Iwasaki A, Ko AI, Mortazavi BJ, Krumholz HM, Schulz WL. Clinical characteristics and outcomes for 7,995 patients with SARS-CoV-2 infection. PLOS ONE 2021, 16: e0243291. PMID: 33788846, PMCID: PMC8011821, DOI: 10.1371/journal.pone.0243291.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionYale New Haven HealthSARS-CoV-2Hospital mortalityRisk of admissionMale sexRisk factorsSARS-CoV-2 testingInvasive mechanical ventilationSevere acute respiratory syndrome virusBurden of diseaseRT-PCR testingAcademic health systemDiverse patient populationsRespiratory syndrome virusEthnic groupsAdult patientsClinical characteristicsDischarge dispositionRespiratory supportPrimary outcomeTreatment guidelinesMechanical ventilationRetrospective studyPatient population
2005
Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.
Stankewicz MA, Mansour CS, Eisner RL, Churchwell KB, Williams BR, Sigman SR, Streeter J, Patterson RE. Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch. Journal Of Nuclear Medicine 2005, 46: 1602-9. PMID: 16204709.Peer-Reviewed Original ResearchConceptsMyocardial viabilityLeft ventriclePresence of severityEvidence of viabilityMyocardial viability assessmentNegative predictive valueViable myocardial tissueSurgical revascularizationCoronary diseaseClinical indicationsMetabolic assessmentSeverity criteriaAssessment of viabilityPET imagesPredictive valueWashout criteriaPatientsFDGQuantitative severityMyocardial tissuePositive criteriaGold standardWashoutSmall restingSeverity